Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Gains from Investment Securities (2019 - 2026)

Atea Pharmaceuticals' Gains from Investment Securities history spans 8 years, with the latest figure at $621809.0 for Q1 2026.

  • Quarterly Gains from Investment Securities fell 97.26% to $621809.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $621809.0 through Mar 2026, down 97.26% year-over-year, with the annual reading at $22.8 million for FY2025, 2059.27% up from the prior year.
  • Gains from Investment Securities came in at $621809.0 for Q1 2026, down from $691762.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $22.7 million in Q1 2025 to a low of $182350.0 in Q3 2022.
  • The 5-year median for Gains from Investment Securities is $724970.0 (2022), against an average of $4.5 million.
  • Year-over-year, Gains from Investment Securities soared 5037.73% in 2024 and then tumbled 97.26% in 2026.
  • Atea Pharmaceuticals' Gains from Investment Securities stood at $182350.0 in 2022, then soared by 9232.23% to $17.0 million in 2023, then crashed by 93.78% to $1.1 million in 2024, then crashed by 34.61% to $691762.0 in 2025, then fell by 10.11% to $621809.0 in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Gains from Investment Securities are $621809.0 (Q1 2026), $691762.0 (Q3 2025), and $1.0 million (Q2 2025).